Ascendia Ranks on Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000

Sep 23, 2020 12:00:00 AM

How to Develop an Effective Formulation Strategy for Early Phase Human Studies

Sep 14, 2020 12:00:00 AM

Nano-Emulsion Formulation Overcomes Injectable Clopidogrel Challenges

Aug 24, 2020 12:00:00 AM

Ascendia’s Technologies Featured in Outsourcing Formulation Development & Manufacturing Special Report

Jul 2, 2020 12:00:00 AM

Nano-Emulsion Technology Creates New Methods to Overcome Poorly Soluble Drug Formulations

Jun 22, 2020 12:00:00 AM

FORMULATION FORUM: Design & Development of Lipid-Filled Delivery Systems

Jun 5, 2020 12:00:00 AM

FORMULATION FORUM: New Drug Candidates Formulation Research Strategy

May 28, 2020 12:00:00 AM

Best Practices When Selecting a CDMO for Drug Formulation

May 19, 2020 12:00:00 AM

Ascendia Patented IP Technologies Featured in Bioavailability & Solubility Report

May 13, 2020 12:00:00 AM

Ascendia Joins the Fight Against COVID-19

Apr 29, 2020 12:00:00 AM

How to Select a CDMO to Improve Drug Bioavailability and Solubility

Apr 20, 2020 12:00:00 AM

State of CDMO Market: Insight from Ascendia

Apr 14, 2020 12:00:00 AM